When Nothing Changes Nothing Changes (Part 1)

During COVID-19 methadone clinics were allowed to relax the stringent rules that had been in place for many decades for the first time. Few of them did so, and our story and interview today center around the entrenched attitudes and ossification that has kept the very treatment systems tasked with helping from doing so. Imagine what everyone else is doing...

This is the first of a two part interview with Irene Garnett and Caty Simon.

Caty Simon has spent 20 years in the low-income rights, psychiatric survivors’ rights, sex workers’ rights, and drug users union movements. She is a leadership team member of and a sex worker liaison for National Survivors Union (NSU), the United States national drug users union. Simon is also a founding co-organizer and co-executive director of Whose Corner Is It Anyway, a Western MA harm reduction, mutual aid, and organizing group by and for low-income, street, and survival sex workers who use opioids and/or stimulants and/or experience housing insecurity. She is the Director of Narrative Development at NC Survivors Union, the flagship affiliate group of NSU, leading Narcofeminism Storyshare, a project reducing stigma against people who use drugs through autobiographical story development and stakeholder training. From 2013 to 2020, Simon was co-editor of Tits and Sass (titsandsass.com), a seminal media outlet by and for sex workers which was featured in the New Yorker, the New York Times, Jezebel, Gawker, and the New Inquiry, to name a few. She is first author of a commentary in the International Journal of Drug Policy on union members’ experiences as drug user organizers doing community driven research (CDR) and an editorial in a health justice and overdose crisis special issue of the American Journal of Public Health, “The methadone manifesto: treatment experiences and policy recommendations from methadone patient activists.” She has extensive experience as a research and intervention consultant representing people with living experience of drug use and drug treatment, and has worked with the Yale Program of Addiction Medicine, the COVID-19 and Substance Use Data Collaborative, the Baystate Hospital Emergency Department,  the National Drug Early Warning System, JBS International, the University of Kentucky’s Department of Behavioral Science, and the University of Colorado’s School of Medicine, among others. Simon recently served on the Substance Abuse and Mental Health Administration’s harm reduction steering committee, defining harm reduction and its principles, precepts, and metrics for the federal agency.